If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £66.18m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Statement re Offer for Subscription

30 Apr 2014 07:01

RNS Number : 8462F
Maven Income and Growth VCT 3 PLC
30 April 2014
 



Maven Income and Growth VCT 3 plc (the "Company")

 

Extension to Offer for Subscription

 

On 24 October 2013, the Company, Maven Income and Growth VCT plc, Maven Income and Growth VCT 2 plc, Maven Income and Growth VCT 4 plc, Maven Income and Growth VCT 5 plc and Maven Income and Growth VCT 6 plc (together "the Companies") announced that they had published a Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares in each of the Companies to raise, in aggregate, up to £20 million (before issue costs) together with an over-allotment facility for up to a further £5 million, in aggregate (the "Offer").

 

The Offer closed on 5 April 2014 in relation to the tax year 2013/14 and was intended to close on 30 April 2014 in relation to the tax year 2014/15 unless fully subscribed by an earlier date or previously extended by the directors of the Company (the "Directors") to no later than 30 September 2014.

 

The Finance Bill 2014 (the "Bill"), published on 27 March 2014, contained proposed changes to regulations which would apply to VCT shares issued on or after 6 April 2014. The Directors have been advised that certain provisions of the Bill are ambiguous and, if an allotment were to be made subsequent to 6 April 2014, could be interpreted in a manner that would have serious and adverse tax consequences for all Shareholders. Although HM Treasury have acknowledged the concerns made by the VCT industry regarding these provisions, and have agreed that amendments will be made to them, the relevant amendments have not yet been published. Any amendments will also be subject to Parliamentary review and debate.

 

Therefore, in the interest of all of the Company's Shareholders, the Directors have decided to postpone any allotment of new Ordinary Shares under the Offer for the 2014/15 tax year, with applications (and application monies) held pending until the Directors believe that there is certainty that allotments can take place without contravening the new rules. At such time when the Directors have been advised that the allotments can be made without adverse effects on the status and operation of the Company, an appropriate announcement will be made.

 

Given that the Directors intended to allot Ordinary Shares for the tax year 2014/15 before the end of April 2014, it was the expectation that all new investors under the Offer would be eligible to receive the final dividend from the Company for the year ended 30 November 2013. However, in view of the above, it is possible that any further allotment of new Ordinary Shares may now take place after the record date for this dividend, in which case the Offer Price will be adjusted under the Pricing Formula for the Offer and will reflect that no dividend payment will be received.

 

In view of the above, the Offer has been extended to 5.00 pm on 30 September 2014 or such earlier date on which the Offer is fully subscribed or on which the directors of the Companies may resolve to close the Offer. In relation to this issue, it is also proposed that a Supplementary Prospectus will be submitted to the UKLA for approval, at which point a further announcement will be made.

 

Any enquiries in respect of this extension to the Offer should be directed to:

 

Maven Capital Partners UK LLP:

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

30 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLFFFLSFIAFIS
Date   Source Headline
6th Apr 20189:21 amRNSDirector/PDMR Shareholding
5th Apr 20186:22 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
9th Mar 20184:16 pmRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
13th Feb 20183:34 pmRNSTransaction in Own Shares
6th Feb 20185:14 pmRNSDirector/PDMR Shareholding
6th Feb 20185:13 pmRNSDirector/PDMR Shareholding
6th Feb 20185:12 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
19th Jan 20183:33 pmRNSNet Asset Value(s)
30th Nov 20174:31 pmRNSIssue of Equity
22nd Nov 20175:06 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:05 pmRNSStatement re NAV and Dividend Investment Scheme
8th Nov 201710:11 amRNSResult of General Meeting
27th Oct 20173:26 pmRNSNet Asset Value(s)
25th Oct 20172:57 pmRNSDividend Declaration
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:45 pmRNSIssue of Equity
15th Sep 201710:05 amRNSStatement re NAV and Dividend Investment Scheme
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
31st Aug 20175:01 pmRNSTransaction in Own Shares
25th Aug 20172:29 pmRNSHalf-year Report
10th Aug 20174:31 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
10th Jul 201710:56 amRNSNet Asset Value(s)
15th Jun 20174:00 pmRNSDividend Declaration
12th May 20174:13 pmRNSTransaction in Own Shares
12th May 20174:07 pmRNSNet Asset Value(s)
11th May 20172:39 pmRNSTransaction in Own Shares
10th May 201712:33 pmRNSTransaction in Own Shares
28th Apr 20173:36 pmRNSDirectorate Change
27th Apr 20171:01 pmRNSNet Asset Value(s)
27th Apr 201712:57 pmRNSResult of AGM
24th Mar 20175:33 pmRNSAnnual Financial Report
26th Jan 20177:00 amRNSNet Asset Value and Proposed Final Dividend
20th Jan 201710:12 amRNSDirectorate Change
8th Nov 20164:49 pmRNSTransaction in Own Shares
7th Nov 201611:00 amRNSDirector/PDMR Shareholding
28th Oct 20168:39 amRNSNet Asset Value(s)
26th Aug 20164:36 pmRNSTransaction in Own Shares
21st Jul 20164:53 pmRNSHalf-year Report
13th Apr 20161:14 pmRNSDirectorate Change
13th Apr 20161:08 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.